Metabolism in vivo of all-trans-[11-3H]retinoic acid after an oral dose in rats. Characterization of retinoyl beta-glucuronide in the blood and other tissues

Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):527-31. doi: 10.1042/bj2770527.

Abstract

Soon after [11-3H]retinoic acid (RA) (1.1 x 10(8) d.p.m.) was administered orally to rats either as a large dose (115 micrograms = 0.38 mumol/rat) or mixed with unlabelled RA as a huge dose (22 mg = 73.33 mumol/rat), retinoyl beta-glucuronide (RAG) was identified and characterized as a significant metabolite in the serum and small intestine. Of the administered dose, 70% remained unchanged as retinoic acid in the stomach up to 1 h. Significant amounts of 5,6-epoxyretinoic acid, 4-hydroxyretinoic acid, esters of retinoic acid and several polar retinoids, including 4-oxoretinoic acid, were also detected in the stomach. No significant difference was observed in the nature of the retinoids found after a large or a huge dose; however, the ratio of RAG/RA was higher after a huge dose than after a large dose. Thus RAG, which is biologically active in vivo and in vitro, is formed quickly in significant amounts in tissues after a dose of RA.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Animals
  • Biotransformation
  • Chromatography, High Pressure Liquid
  • Female
  • Male
  • Pregnancy
  • Radioisotope Dilution Technique
  • Rats
  • Rats, Inbred Strains
  • Time Factors
  • Tissue Distribution
  • Tretinoin / administration & dosage
  • Tretinoin / analogs & derivatives*
  • Tretinoin / analysis
  • Tretinoin / blood
  • Tretinoin / metabolism*
  • Tretinoin / pharmacokinetics
  • Tritium

Substances

  • Tritium
  • retinoyl glucuronide
  • Tretinoin